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Background: To evaluate the effect of oral appliance (OA) on upper airway
morphology and its relationship with treatment response in subjects with obstructive
sleep apnoea (OSA).
Methods: Symptomatic OSA subjects were recruited. Non-adjustable OA was custom
made. Variables examined at baseline and while wearing the device at 2 months
included polysomnographic data, computed tomographic measurements of upper
airway cross sectional area at level of velopharynx (VA) and hypopharynx (HA), upper
airway volume, and cephalometric parameters. Treatment outcome was based on
post-treatment apnoea–hypopnoea index (AHI).
Results: Forty patients were recruited and 23 (7 women) completed the study. They
were middle-aged (49, 40–58 years) (median, interquartile range) and overweight
(BMI 26, 23.3–29.5 kg/m2), with moderate OSA (AHI 26.4, 14.1–36). The overall post
treatment AHI was 8.4 (2.4–12.5), with 14 (61%) patients showing good response
(AHIo10), and the other 9 patients showing moderate response (450% reduction in
AHI but still X10). OA decreased the cross-sectional area of the HA (P ¼ 0.046),
showed a trend of decreasing the ratio of cross-sectional area of the HA to cross-
sectional area of the VA (P ¼ 0.053) and significantly increased the overall upper
airway volume (P ¼ 0.006, n ¼ 11). No significant relationship between upper airway
parameters and treatment outcome was identified.
Conclusions: OA altered upper airway morphometry towards a profile consistent
with decreased propensity to collapse, which may thus have contributed to
improvement of OSA.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Oral appliance (OA) has been suggested as an
alternative treatment in patients with mild to
moderate obstructive sleep apnoea (OSA), and
who cannot tolerate continuous positive airway
pressure (CPAP),1–4 but treatment response varies
in individuals. Understanding the working mechan-
isms of OA and predictors of treatment response
will help in selecting appropriate candidates for
this treatment. Changes in morphology and dimen-
sions of the upper airway, and increase in upper
airway muscular tone, resulting in less collapsible
upper airway, have been proposed to be the
working mechanisms of OA.5–9 This study was
designed to evaluate the effects of OA on upper
airway parameters and their relationship with
treatment response.Materials and methods
Patient recruitment
Consecutive patients who attended Sleep Labora-
tory at Queen Mary Hospital for suspected OSA were
interviewed after diagnostic polysomnogram (PSG).
Patients with mild to moderate OSA were recruited
for OA treatment with written consent. Other
inclusion criteria included: age 418 years, exces-
sive daytime sleepiness as evidenced by Epworth
sleepiness score (ESS) 9 or above, adequate denti-
tion and ability to protrude mandible forward.
Exclusion criteria included inadequate healthy
teeth for retention of OA, active periodontal
disease, history or presence of temporo-mandibular
joint (TMJ) pain and/or trismus, obvious anatomic/
pathological airway obstruction, high risk occupa-
tion, e.g. driver, or unstable medical disease.
Institutional Ethics Committee approved the study.Figure 1 Oral appliance used in this study.Study design
After baseline PSG, subjects who fulfilled the
relevant study criteria and consented to the study
were referred to the orthodontist (SK) for dental
assessment. Those who were considered suitable
for the device underwent lateral cephalometry and
computed tomography (CT) of the upper airway
while the device was being fabricated. Subjects
were then advised to use the OA every night during
sleep. They were re-assessed after using the device
for 2 months. At reassessment, compliance and side
effects of treatment and symptoms of sleep apneawere documented; lateral cephalometry and CT
were repeated as described below.
Oral appliance (Fig. 1)
The OA was made of dental acrylic that was
modified from a functional activator (Harvold
type). It held the mandible in a forward direction
with some vertical opening. The appliances were
custom made for individual patients by one
orthodontist. The patient was instructed to open
and protrude the mandible as far as possible, then
to relax and retract the mandible slowly to a
comfortable position. This movement was repeated
several times until the patient could reach the most
advanced position without causing discomfort, and
the OA was moulded at this jaw position. If fatigue
or soreness developed on wearing the device, a
new OA would be prepared with a less protrusive
and more comfortable mandibular position.
Sleep study
All subjects underwent overnight PSG at the Sleep
Laboratory at Queen Mary Hospital (Alice 3 Diag-
nostics System, Respironics, Pennsylvania, US)
with documentation of sleep stages by electro-
encephalogram, electro-oculography, and electro-
myography; respiratory movement by impedance
plethysmography; airflow by nasal pressure sensor
with thermistor backup, arterial oxygen saturation
by pulse oximetry, snoring by tracheal microphone,
and sleep position by position sensor. Data were
manually scored according to standard criteria.10–12
The average number of episodes of apnoea and
hypopnoea per hour of sleep (the apnoea–hypop-
noea index, AHI) was calculated as the summary
measurement of sleep disordered breathing. At re-
assessment, PSG was performed with patients
wearing their OA.
ARTICLE IN PRESS
Oral appliance and obstructive sleep apnoea 899Computed tomography (CT)
All CT examinations were performed with the
subject awake and head in a neutral (midway
between flexion and extension) supine position
using a Hi-speed Advantage scanner (General
Electric Medical System, Milwaukee, Wisconsin,
USA). Computed tomographic scan of the head
and neck region was done for measurement of
upper airway cross-sectional areas at two levels:
velopharynx (VA) and hypopharynx (HA), upper
airway volume as well as cephalometric para-
meters. The VA and HA cross-sectional area were
measured at the tip of the uvula and floor of
vallecula, respectively, as determined on the
lateral scannogram. Scan parameters included
120 kV, 120mA, and scan thickness 5mm with
image acquisition obtained during quite tidal
breathing. The cross-sectional areas of the upper
airway at the VA and HA were manually measured
using electronic calipers. The ratio of these two
measurements (HA/VA) was also obtained.
Volumetric helical CT scanning of the upper
airway was additionally performed in patients
who consented. The lateral scannogram allowed
selection of scan levels with the hard palate and
superior thyroid cornu defining the superior and
inferior scan limits. Volumetric data were obtained
in full expiration of a quite breath. Scan para-
meters included 120 Kv, 160mA, pitch 1:5, scan
thickness 5mm and scan interval 2.5mm. All data
were transferred to a free-standing Graphics work-
station, where airway volume was determined
using volume rendering three-dimensional CT
method to disarticulate air from soft tissues.
Cephalometric measurements were made on the
lateral scout view using an electronic cursor at the
CT station. Four standard measurements were
taken, according to standard protocol13 for the
subsequent purpose of analysis of relationship
between the upper airway parameters and adja-
cent bony anatomy. They were: SNA, the angle
between the sellar point, the nasion, and theTable 1 Demographic and PSG data.
Baseline
Body mass index (kg/m2) 26 (23.3–29.5
ESS 13 (10–15)
AHI 26.4 (14.1–36
Sleep efficiency (%) 79.5 (70.1–90
Oxygen saturation o90% (mins) 16 (8–52)
All parameters stated by median (interquartile range) un
AHI ¼ apnoea–hypopnoea index.subspinale; SNB, the angle between the sellar
point, the nasion, and the supramentale; ANB,
subtract SNB from SNA; and MPH, the shortest
perpendicular distance between the plane of the
inferior mandibular cortex and the hyoid bone.
Treatment response
This was based on the AHI documented by PSG. A
decrease in AHI while wearing OA signified an
improvement. Good response was defined as post-
treatment AHIo10, moderate response as post-
treatment AHI less than 50% of baseline but still
X10, poor responder as post-treatment AHIX50%
of baseline AHI.
Statistical analysis
Data are presented as median with interquartile
range. Wilcoxon signed rank test was used to
compare parameters without and with OA. Mann
Whitney test was used for comparison between
subjects with different treatment response. Spear-
man’s correlation was used to assess the relation-
ship between various parameters and AHI.
Statistical significance was taken at Po0:05.Results
Patient demography and PSG data (Table 1)
Of forty patients referred to the orthodontist, 14
were deemed not suitable for OA due to dental
reasons and 26 were recruited into the study with
OA fabrication. One patient lost his OA and was
unwilling to continue in the study, another two
patients refused to come back for re-assessment,
giving 23 (7 women) evaluable patients. These
patients were middle-aged (49 years, 40–58) and
overweight or obese by Asian criteria (body mass
index: 26 kg/m2, 23.3–29.5).14 They had sympto-2 months P value
) 26 (23.8–30.1) NS
7 (5–11) 0.001
) 8.4 (2.4–12.5) o0.001
.3) 83.5 (71.2–88.3) NS
2.5 (0.5–22.5) o0.001
less otherwise stated ESS ¼ Epworth sleepiness score;
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ESS of 26.4 (14.1–36) and 13 (10–15), respectively.Efficacy, compliance and complications
At reassessment at two months, sleep apnoea
improved as a group (Table 1). Fourteen (61%)
patients showed good response [AHI decreased from
16.5 (11.9–27.3) to 3.4 (1.9–7.5, P ¼ 0:001)] and
nine showed moderate response [AHI decreased
from 36 (32.5–40.1) to 16.2 (11.4–26.5)](P ¼ 0:008).
Self-reported compliance was 88% (6 nights per
week, 6–8 h per night). Complications of treatment
were minor and no subject dropped out of the study
due to side effects.Upper airway parameters
Evaluation while wearing OA at 2 months showed a
significant decrease in the cross-sectional area of
the HA and a trend of decreasing the HA/VA ratio
(Table 2). Fig. 2 demonstrates the cross-sectional
change at the HA in a patient as shown on CT.
Only 11 of the 23 patients consented to undergo
volumetric CT scans. An increase in upper airway
volume after the application of OA was seen in
all and the mean upper airway volume changed
from 65.7mm3 (39.4–77.9) to 70.8mm3 (56.3–94.2)
(P ¼ 0.006).
There was no significant relationship between
any of the upper airway parameters and cephalo-
metric variables (data not shown).Table 2 Upper airway, cephalometric and dental param
Baseline
Upper airway and cephalometric measurements on CT
Velopharynx airway, VA (mm2) 157 (110–261)
Hypopharyx airway, HA (mm2) 369 (301–478)
HA/VA 2.21 (1.48–4.11
Upper airway volume (mm3) 65.7 (39.4–77.9
SNA (1) 96 (90–101)
SNB (1) 90 (88–95)
ANB (1) 6 (2–7)
MPH (mm) 21 (16–24)
Dental parameters on lateral cephalometric radiograph
Incisal separation (mm)
Advancement (mm)
All parameters stated by median (interquartile range) unless oth
SNA ¼ angle between the sellar point, the nasion, and the subspina
supramentale; ANB ¼ subtract SNB from SNA; MPH ¼ shortest
mandibular cortex and the hyoid bone.
Numbers of subjects ¼ 11.Relationship between upper airway
parameters and treatment outcome
There was no significant difference between good
and moderate responders in cross-sectional areas
at VA and HA, HA to VA ratio, and total upper airway
volume, either at baseline or while wearing OA.
There was no significant correlation between these
upper airway variables and AHI, at baseline or
wearing OA, nor between their changes with OA
(data not shown).Discussion
The results of this study showed that OA resulted in
improvement of OSA to varying degrees, while the
upper airway demonstrated significant decrease in
cross-sectional area at the HA, a trend of decrease
in HA/VA ratio, and an increase in overall upper
airway volume. However, we did not identify any
significant relationship between upper airway
parameters and treatment outcome.
Previous studies have evaluated upper airway
changes with OA using X-ray cephalometry. It has
been shown that OA decreased the curvature at the
VA while increasing its size, both of which helped to
prevent the loss of potential energy which would
have led to velopharyngeal collapse.9 Using mag-
netic resonance imaging, it has been demonstrated
that hypopharyngeal size might decrease or in-
crease depending on the amplitude of mandibulareters with and without OA.
2 months (with OA) P value
200 (135–315) NS
307 (242–451) 0.046
) 1.62 (1.24–2.16) 0.053
) 70.8 (56.3–94.2) 0.006
96 (93–100) NS
91 (89–97) NS
5 (2–7) NS
15 (8–18) o0.001
8.5 (7.8–10.5)
5 (3.4–6.3)
erwise stated.
le; SNB ¼ angle between the sellar point, the nasion, and the
perpendicular distance between the plane of the inferior
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Figure 2 CT cross-section at level of hypopharynx with-
out OA (a) and while wearing OA (b).
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were not able to find any significant increase in
velopharyneal area, but we showed a selective
decrease in the hypopharyngeal lumen and the HA
to VA ratio. This finding is consistent with previous
work, which demonstrated that OA led to signifi-
cant forward movement of the anterior wall of the
VA and the posterior wall of the HA in good
responders but not in poor responders.16 Though
the increase in velopharyngeal lumen after OA did
not reach statistical significance in our subjects,
the overall increase in upper airway volume
concomitant with a decrease in the size of the HA
would suggest that the size of the VA has increased.
Possible explanations for the decrease in hypophar-
yngeal area are that advancement of the mandible
led to a decrease in dilator muscle tone ofhypopharyngeal region or a downward shift of the
mandible, especially the anterior aspect, which
thus encroached on the HA.
The improvement in sleep apnoea despite a
decrease in size of part of the upper airway is
apparently paradoxical, but previous literature
have reported a smaller HA or a relatively larger
ratio of the VA to HA in non-OSA subjects compared
to OSA subjects.17–20 Furthermore, uvulopalato-
pharyngoplasty produced a decrease in the hypo-
pharyngeal area with an increase in velopharyngeal
area, and this pattern of change was more
pronounced in those who showed good response
to the surgery.20 It has been hypothesized that a
smaller HA may protect against the development of
OSA, because if the peak inspiratory suction
pressure could be damped down at the relatively
narrowed HA, the more collapsible VA would be less
prone to close.19 Hence, the morphological changes
of the upper airway with OA seen in this study is
consistent with a reversal of the predisposing
configuration, and may explain the therapeutic
effect of the device, while the failure to achieve, in
addition, a significant increase in VA size, may
explain its limited efficacy compared to other
treatment modalities like CPAP.
The overall increase in upper airway volume
after OA application suggests that it is one of the
mechanisms by which OA improves OSA. Although it
is controversial whether OSA subjects have a
narrower upper airway,21,22 it is reasonable that a
larger lumen will allow a smaller risk of obstruction
when the upper airway is subjected to the same
dynamic collapsing force. Studies have reported
that OA resulted in less collapsible upper airway in
OSA subjects.8,9
All subjects in this study showed some improve-
ment in sleep apnoea after OA, albeit to varying
extents. We were not able to demonstrate any
relationship between changes in upper airway
parameters and improvement in sleep apnoea. This
is not surprising in view of the complex pathophy-
siologic mechanisms underlying the development of
OSA, which would involve an interplay of anatomic
factors and neuromuscular dynamics at the upper
airway and not merely physical dimensions of the
upper airway, given the limited sample size.
This study has several limitations. Imaging
evaluations were performed with the patient
awake, which may not reflect the anatomical-
physiological conditions during sleep. Logistically,
it is extremely difficult to image the upper airway
with CT or X-ray during sleep. Another limitation is
that non-adjustable OA were used instead of
adjustable ones. It is possible that adjustable OA
may result in further advancement of the mandible
ARTICLE IN PRESS
K. Sam et al.902with better treatment outcome,23 and thus allow
better discrimination of the upper airway changes
associated with treatment response. Nonetheless,
it has been shown that an advancement of 67% of
the maximum value produced the same effect on
upper airway morphometry as maximum advance-
ment.16 Finally, the relatively small sample size
with large individual variation in baseline charac-
teristic could have limited the power to identify
some of the upper airway changes and the relation-
ships to treatment response.
In summary, our findings suggest that OA can
modify upper airway morphology and the resultant
profile may favor less dynamic collapse of the upper
airway. This may be one of the mechanisms by
which OA improves OSA.Acknowledgments
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